• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化应激控制调节性T细胞凋亡、抑制活性以及肿瘤中程序性死亡配体1(PD-L1)阻断抗性。

Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor.

作者信息

Maj Tomasz, Wang Wei, Crespo Joel, Zhang Hongjuan, Wang Weimin, Wei Shuang, Zhao Lili, Vatan Linda, Shao Irene, Szeliga Wojciech, Lyssiotis Costas, Liu J Rebecca, Kryczek Ilona, Zou Weiping

机构信息

Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.

Department of Immunology and Key Laboratory of Medical Immunology of the Ministry of Public Health, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

出版信息

Nat Immunol. 2017 Dec;18(12):1332-1341. doi: 10.1038/ni.3868. Epub 2017 Oct 30.

DOI:10.1038/ni.3868
PMID:29083399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5770150/
Abstract

Live regulatory T cells (T cells) suppress antitumor immunity, but how T cells behave in the metabolically abnormal tumor microenvironment remains unknown. Here we show that tumor T cells undergo apoptosis, and such apoptotic T cells abolish spontaneous and PD-L1-blockade-mediated antitumor T cell immunity. Biochemical and functional analyses show that adenosine, but not typical suppressive factors such as PD-L1, CTLA-4, TGF-β, IL-35, and IL-10, contributes to apoptotic T-cell-mediated immunosuppression. Mechanistically, apoptotic T cells release and convert a large amount of ATP to adenosine via CD39 and CD73, and mediate immunosuppression via the adenosine and A pathways. Apoptosis in T cells is attributed to their weak NRF2-associated antioxidant system and high vulnerability to free oxygen species in the tumor microenvironment. Thus, the data support a model wherein tumor T cells sustain and amplify their suppressor capacity through inadvertent death via oxidative stress. This work highlights the oxidative pathway as a metabolic checkpoint that controls T cell behavior and affects the efficacy of therapeutics targeting cancer checkpoints.

摘要

存活的调节性T细胞(T细胞)会抑制抗肿瘤免疫,但T细胞在代谢异常的肿瘤微环境中的行为仍不清楚。在此,我们发现肿瘤T细胞会发生凋亡,且这种凋亡的T细胞会消除自发的以及PD-L1阻断介导的抗肿瘤T细胞免疫。生化和功能分析表明,促成凋亡T细胞介导的免疫抑制的是腺苷,而非PD-L1、CTLA-4、TGF-β、IL-35和IL-10等典型抑制因子。从机制上来说,凋亡的T细胞通过CD39和CD73释放并将大量ATP转化为腺苷,并通过腺苷和A通路介导免疫抑制。T细胞中的凋亡归因于其与NRF2相关的抗氧化系统较弱,以及在肿瘤微环境中对活性氧的高敏感性。因此,这些数据支持了一种模型,即肿瘤T细胞通过氧化应激导致的意外死亡来维持并增强其抑制能力。这项工作突出了氧化途径作为一个代谢检查点,它控制T细胞行为并影响靶向癌症检查点的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/309f88b609c9/nihms930217f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/3a59de9018be/nihms930217f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/96a929ddf4f2/nihms930217f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/3fc01230010f/nihms930217f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/cd565e6bf6c3/nihms930217f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/36cb67966ee6/nihms930217f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/309f88b609c9/nihms930217f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/3a59de9018be/nihms930217f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/96a929ddf4f2/nihms930217f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/3fc01230010f/nihms930217f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/cd565e6bf6c3/nihms930217f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/36cb67966ee6/nihms930217f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6285/5770150/309f88b609c9/nihms930217f6.jpg

相似文献

1
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor.氧化应激控制调节性T细胞凋亡、抑制活性以及肿瘤中程序性死亡配体1(PD-L1)阻断抗性。
Nat Immunol. 2017 Dec;18(12):1332-1341. doi: 10.1038/ni.3868. Epub 2017 Oct 30.
2
Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.细胞外嘌呤代谢和 CD73 衍生的腺苷在小鼠 Treg 和 Teff 细胞中的信号转导。
Am J Physiol Cell Physiol. 2011 Aug;301(2):C530-9. doi: 10.1152/ajpcell.00385.2010. Epub 2011 May 18.
3
Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.腺苷及腺苷A2A受体激动剂CGS21680通过E2F-1和CREB上调从脓毒症小鼠分离出的调节性T细胞中CD39和CD73的表达。
Int J Mol Med. 2016 Sep;38(3):969-75. doi: 10.3892/ijmm.2016.2679. Epub 2016 Jul 14.
4
Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.特异性阻断 CD73 改变头颈部鳞状细胞癌中 T 细胞的“耗竭”表型。
Int J Cancer. 2018 Sep 15;143(6):1494-1504. doi: 10.1002/ijc.31534.
5
Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.非小细胞肺癌中核苷酸酶 CD73 和 CD39 的表达与缺氧和免疫抑制途径有关。
Life Sci. 2020 Oct 15;259:118389. doi: 10.1016/j.lfs.2020.118389. Epub 2020 Sep 6.
6
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer.高等级浆液性卵巢癌中腺苷通路的高维分析。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001965.
7
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.卵巢癌细胞表面的外核苷酸酶 CD39 和 CD73 是产生腺苷的有效酶,可导致腺苷受体 2A 依赖性 T 细胞功能抑制和 NK 细胞细胞毒性。
Cancer Immunol Immunother. 2011 Oct;60(10):1405-18. doi: 10.1007/s00262-011-1040-4. Epub 2011 Jun 3.
8
Autocrine Adenosine Regulates Tumor Polyfunctional CD73CD4 Effector T Cells Devoid of Immune Checkpoints.自分泌腺苷调节肿瘤多功能 CD73CD4 效应 T 细胞,而不依赖免疫检查点。
Cancer Res. 2018 Jul 1;78(13):3604-3618. doi: 10.1158/0008-5472.CAN-17-2405. Epub 2018 Mar 20.
9
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.在多发性骨髓瘤中,通过 CD39 和 CD73 将 ATP 转化为腺苷,可以与腺苷受体 A2A 阻断一起成功靶向。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2020-000610.
10
CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells.CXCR4 抑制作用可逆转转移性 NSCLC 干细胞的免疫抑制特性。
Front Immunol. 2020 Oct 2;11:02168. doi: 10.3389/fimmu.2020.02168. eCollection 2020.

引用本文的文献

1
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers.癌症中的氧化应激:从肿瘤与微环境重塑到治疗前沿
Mol Cancer. 2025 Aug 22;24(1):219. doi: 10.1186/s12943-025-02375-x.
2
Mitochondria reactive oxygen species signaling-dependent immune responses in macrophages and T cells.巨噬细胞和T细胞中线粒体活性氧信号依赖性免疫反应。
Immunity. 2025 Aug 12;58(8):1904-1921. doi: 10.1016/j.immuni.2025.07.012. Epub 2025 Aug 4.
3
Recent Advances in Nanotechnology-Based Approaches for Ferroptosis Therapy and Imaging Diagnosis in Pancreatic Cancer.

本文引用的文献

1
Ionic immune suppression within the tumour microenvironment limits T cell effector function.肿瘤微环境中的离子免疫抑制会限制T细胞效应功能。
Nature. 2016 Sep 22;537(7621):539-543. doi: 10.1038/nature19364. Epub 2016 Sep 14.
2
A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.肿瘤浸润性T细胞中与激活解偶联的功能障碍相关的独特基因模块。
Cell. 2016 Sep 8;166(6):1500-1511.e9. doi: 10.1016/j.cell.2016.08.052.
3
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche.
基于纳米技术的胰腺癌铁死亡治疗与成像诊断方法的最新进展
Pharmaceutics. 2025 Jul 20;17(7):937. doi: 10.3390/pharmaceutics17070937.
4
Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer.卵巢癌中调节性T细胞的免疫抑制机制及治疗靶点
Front Immunol. 2025 Jul 9;16:1631226. doi: 10.3389/fimmu.2025.1631226. eCollection 2025.
5
Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity.通过靶向FSP1选择性破坏肿瘤内调节性T细胞中的脂质过氧化物稳态可增强癌症免疫力。
bioRxiv. 2025 Jul 11:2025.07.06.663397. doi: 10.1101/2025.07.06.663397.
6
Mitochondrial unfolded protein response in regulatory T cell function: a protective mechanism in immune aging.线粒体未折叠蛋白反应在调节性T细胞功能中的作用:免疫衰老中的一种保护机制
Front Immunol. 2025 Jun 30;16:1621759. doi: 10.3389/fimmu.2025.1621759. eCollection 2025.
7
Daurisoline Modulates the TBK1-Dependent Type I Interferon Pathway to Boost Anti-tumor Immunity via Targeting of LRP1.蝙蝠葛碱通过靶向低密度脂蛋白受体相关蛋白1(LRP1)调节TBK1依赖的I型干扰素途径以增强抗肿瘤免疫。
Research (Wash D C). 2025 Jul 4;8:0764. doi: 10.34133/research.0764. eCollection 2025.
8
Insights from Clinical Trials on A Adenosine Receptor Antagonists for Cancer Treatment.A腺苷受体拮抗剂用于癌症治疗的临床试验见解。
ACS Pharmacol Transl Sci. 2025 May 2;8(6):1498-1512. doi: 10.1021/acsptsci.5c00057. eCollection 2025 Jun 13.
9
The tumor microenvironment's role in the response to immune checkpoint blockade.肿瘤微环境在免疫检查点阻断反应中的作用。
Nat Cancer. 2025 Jun 13. doi: 10.1038/s43018-025-00986-3.
10
Regulatory T cells in the tumour microenvironment.肿瘤微环境中的调节性T细胞。
Nat Rev Cancer. 2025 Jun 10. doi: 10.1038/s41568-025-00832-9.
T细胞的氧感知建立了免疫耐受的转移微环境。
Cell. 2016 Aug 25;166(5):1117-1131.e14. doi: 10.1016/j.cell.2016.07.032.
4
Fundamentals of cancer metabolism.癌症代谢基础。
Sci Adv. 2016 May 27;2(5):e1600200. doi: 10.1126/sciadv.1600200. eCollection 2016 May.
5
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer.效应T细胞消除卵巢癌中基质介导的化疗耐药性。
Cell. 2016 May 19;165(5):1092-1105. doi: 10.1016/j.cell.2016.04.009. Epub 2016 Apr 28.
6
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.两种 FOXP3(+)CD4(+) T 细胞亚群可明显控制结直肠癌的预后。
Nat Med. 2016 Jun;22(6):679-84. doi: 10.1038/nm.4086. Epub 2016 Apr 25.
7
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.用于癌症治疗的PD-L1(B7-H1)和PD-1通路阻断:作用机制、反应生物标志物及联合应用
Sci Transl Med. 2016 Mar 2;8(328):328rv4. doi: 10.1126/scitranslmed.aad7118.
8
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction.癌症通过糖酵解限制靶向微小RNA和EZH2来介导效应T细胞功能障碍。
Nat Immunol. 2016 Jan;17(1):95-103. doi: 10.1038/ni.3313. Epub 2015 Nov 2.
9
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.TH1型趋化因子的表观遗传沉默塑造肿瘤免疫和免疫疗法。
Nature. 2015 Nov 12;527(7577):249-53. doi: 10.1038/nature15520. Epub 2015 Oct 26.
10
Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients.KW-0761 治疗癌症患者的人源化抗 CCR4 抗体诱导 FoxP3+CD4+Treg 耗竭的 I 期临床研究。
Clin Cancer Res. 2015 Oct 1;21(19):4327-36. doi: 10.1158/1078-0432.CCR-15-0357.